Recent Deals

"Coming up with hidden critical issues."
Nalco Company
Vaclav Harant, General Director for Russia and CIS
"The team of real professionals, each of them capable, when necessary, of providing robust legal support for achieving any business objective."
Siberian Coal Energy Company (SUEK)
Alexander Redkin, Legal Director
"We would like to note the impeccable quality of the services provided to us and the high standard of professionalism demonstrated by the team, together with a profound understanding of our business specifics and strategic mission."
Sibur
Aleksey Nikiforov, Legal Support,
"… a profound understanding of how the Russian energy industry ticks and an impressive track record of energy and infrastructure projects, including with an international footprint."
RusHydro
Dmitry Panchenko, Legal Director
"An undeniable strength of the firm is its high level of competence and the ability to find the best solution to complex legal challenges."
United Metallurgical Company (OMK)
Vladimir Markin, President

Teva Pharmaceutical Industries

Healthcare and Pharmaceuticals
Representing the client in bankruptcy proceedings of its debtor, a big pharmaceutical company. The bankruptcy proceedings are complicated by supposedly insufficient assets disposed of to the debtor’s affiliates and the need to seek out the debtor’s assets. The bankruptcy is also complicated by a multiplicity of creditors (including several well-known bank pledgeholders).

Teva Pharmaceutical Industries Ltd.

Healthcare and Pharmaceuticals

The BCLP team defended a transnational pharma company in a dispute with a major Russian insurer over recovery of insurance compensation. The claims were based on a commercial loan insurance agreement obligating the insurer to reimburse the insured’s losses arising from its counterparties delaying payments under supply contracts.

The defendant refused to pay out the insurance compensation, arguing termination of coverage after delay by the counterparty beyond the maximum period permitted under the insurance agreement. Yet the insurer renewed the policy even though it was aware of the delay.  

BCLP lawyers presented a consistent position arguing the insurer’s bad faith and inconsistent conduct and that the agreement terms were to be interpreted in the insured’s favour.

This case might be of interest for interpreting insurance agreement terms relating to termination of coverage and for assessing insurers’ professional actions. The matter is of special significance for insurance of large-scale supplies of medicines.

Danone, Guardian Industries, Kimberly-Clark and many others

FMCG
Automotive
Healthcare and Pharmaceuticals
Food & Beverages / Restaurants
Provided comprehensive legal support to Nissan Motor, Danone, Guardian Industries, Kimberly-Clark, Kronospan, Lafarge, Magna Automotive, Mars, Oriflame, TEVA Pharmaceutical, Efes Brewery and many others for various Greenfield industrial development projects in different regions. Matters advised on included acquisition of land plots for development, forest and farm land re-zoning, liaisons with authorities, public procedures, regulatory issues and licences, design and construction, environmental, project financing, infrastructure and utilities, litigation and legislative work in the federal, regional and municipal parliaments.

NPK Katren

Healthcare and Pharmaceuticals
Advised NPK Katren on matters involving anti-bribery policies and a range of antitrust matters, including compliance requirements, supply and shortage of goods, etc.

Johnson & Johnson

Healthcare and Pharmaceuticals
FMCG
Advised Johnson & Johnson’s medical devices division on competition law compliance and trade terms development.

Bio-Rad Laboratories

Healthcare and Pharmaceuticals
Defended the position of Bio-Rad Laboratories, a big medical device and medicament producer and supplier, thereby depriving a distributor of the possibility of continuing to use its exclusive status for distributing the goods in the Russian Federation. In addition, as a result of the successful judicial work, the debtor was convinced to conclude an amicable agreement to repay a debt of over RUB 52 m to our client.

Major pharmaceutical company

Healthcare and Pharmaceuticals
Developed a legal position and assisted with initiating an FAS case against competitors for advertising biologically active supplements under names coinciding with those of prescription medicaments (surrogate advertising). Having considered the case, the regulator ruled that such advertising was inadmissible.

A major German pharmaceutical company

Healthcare and Pharmaceuticals
Our lawyers represented the interests of a major German pharmaceutical company in a series of patent disputes relating to the client’s inventions initiated under statements of claim filed by companies producing generic medications.

Sanofi

Healthcare and Pharmaceuticals
Acting for Sanofi, won a series of customs classification cases heard by the Federal Arbitrazh (Commercial Court) for the Central Circuit, despite negative customs practice and case history on classification of similar goods elsewhere in Russia. The amount in dispute was over RUB 100 m per annum.